ACAD
36.32
+0.49
+1.37%
AEMD
0.967
-0.013
-1.2857%
APRI
1.81
-0.01
-0.55%
ARNA
27.29
-0.02
-0.07%
ATEC
4.18
+0.06
+1.46%
CNAT
5.104
+0.094
+1.8802%
CRXM
0.137
+0.034
+32.9767%
CYTX
0.485
+0.02
+4.301%
DXCM
44.9
-0.08
-0.18%
GNMK
7.86
+0.02
+0.26%
HALO
17.84
+0.07
+0.39%
ILMN
209.63
+4.45
+2.17%
INNV
0.087
0.00
0.00%
INO
6.3
+0.05
+0.80%
ISCO
1.65
+0.11
+7.14%
ISIS
57.56
0.00
0.00%
LGND
144.7
+1.35
+0.94%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
-0.03
-4.03%
MEIP
2.63
+0.01
+0.38%
MNOV
6.15
-0.04
-0.65%
MRTX
15.832
+0.282
+1.8109%
MSTX
0.13
-0.01
0.00%
NBIX
59.406
+0.446
+0.756%
NUVA
55.32
+0.75
+1.37%
ONCS
1.26
-0.03
-2.33%
ONVO
1.629
+0.229
+16.3857%
OREX
1.79
-0.03
-1.65%
OTIC
3.425
-0.05
-1.439%
QDEL
41.65
-0.3
-0.72%
RCPT
231.96
0.00
0.00%
RGLS
1.22
-0.03
-2.40%
RMD
79.29
+0.5
+0.63%
SCIE
0
0.00
0.00%
SPHS
2.321
+0.081
+3.616%
SRNE
2.73
+0.23
+9.20%
TROV
0.807
-0.002
-0.2472%
VICL
2.34
-0.04
-1.68%
VOLC
18
0.00
0.00%
ZGNX
40
+0.35
+0.88%
ACAD
36.32
+0.49
+1.37%
AEMD
0.967
-0.013
-1.2857%
APRI
1.81
-0.01
-0.55%
ARNA
27.29
-0.02
-0.07%
ATEC
4.18
+0.06
+1.46%
CNAT
5.104
+0.094
+1.8802%
CRXM
0.137
+0.034
+32.9767%
CYTX
0.485
+0.02
+4.301%
DXCM
44.9
-0.08
-0.18%
GNMK
7.86
+0.02
+0.26%
HALO
17.84
+0.07
+0.39%
ILMN
209.63
+4.45
+2.17%
INNV
0.087
0.00
0.00%
INO
6.3
+0.05
+0.80%
ISCO
1.65
+0.11
+7.14%
ISIS
57.56
0.00
0.00%
LGND
144.7
+1.35
+0.94%
LPTN
2.93
-2.93
-100.00%
MBVX
0.71
-0.03
-4.03%
MEIP
2.63
+0.01
+0.38%
MNOV
6.15
-0.04
-0.65%
MRTX
15.832
+0.282
+1.8109%
MSTX
0.13
-0.01
0.00%
NBIX
59.406
+0.446
+0.756%
NUVA
55.32
+0.75
+1.37%
ONCS
1.26
-0.03
-2.33%
ONVO
1.629
+0.229
+16.3857%
OREX
1.79
-0.03
-1.65%
OTIC
3.425
-0.05
-1.439%
QDEL
41.65
-0.3
-0.72%
RCPT
231.96
0.00
0.00%
RGLS
1.22
-0.03
-2.40%
RMD
79.29
+0.5
+0.63%
SCIE
0
0.00
0.00%
SPHS
2.321
+0.081
+3.616%
SRNE
2.73
+0.23
+9.20%
TROV
0.807
-0.002
-0.2472%
VICL
2.34
-0.04
-1.68%
VOLC
18
0.00
0.00%
ZGNX
40
+0.35
+0.88%
Home » Events, SDBN Events

SDBN Networking Event Featuring Fate Therapeutics & Stemgent

Submitted by on July 1, 2009 – 11:41 am

The San Diego Biotechnology Network’s July 21st event will feature Fate Therapeutics and Stemgent, two companies engaged in exciting, interdisciplinary biotechnology research in San Diego that holds direct promise for making a difference in our quality of life. Ken Batchelor, Ph.D., CSO, Fate Therapeutics, and Stephen Chang, Ph.D., CSO, Stemgent will present a short talk which will be followed by networking:

CATALYST: The Industrialization of Advanced iPSC Technology for Drug Discovery & Development

For more information visit http://sdbn.org/july

Be Sociable, Share!